DrugPatentWatch Database Preview
Drugs in Development Information for Vilaprisan
» See Plans and Pricing
What is the drug development status for Vilaprisan?
Vilaprisan is an investigational drug.
There have been 15 clinical trials for Vilaprisan.
The most recent clinical trial was a Phase 2 trial, which was initiated on July 31st 2017.
The most common disease conditions in clinical trials are Leiomyoma, Myofibroma, and Endometriosis. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are three US patents protecting this investigational drug and eighty-three international patents.
Summary for Vilaprisan
| US Patents | 3 |
| International Patents | 83 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-07-31) |
| Vendors | 3 |
Recent Clinical Trials for Vilaprisan
| Title | Sponsor | Phase |
|---|---|---|
| Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | Bayer | Phase 3 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis | Bayer | Phase 2 |
| A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding | Bayer | Phase 3 |
Clinical Trial Summary for Vilaprisan
Top disease conditions for Vilaprisan
Top clinical trial sponsors for Vilaprisan
US Patents for Vilaprisan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vilaprisan | Start Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | Start Trial |
| Vilaprisan | Start Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | Bayer Pharma Aktiengesellschaft (Berlin, DE) | Start Trial |
| Vilaprisan | Start Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vilaprisan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vilaprisan | Argentina | 077491 | 2029-07-20 | Start Trial |
| Vilaprisan | Australia | 2010275849 | 2029-07-20 | Start Trial |
| Vilaprisan | Brazil | 112012001344 | 2029-07-20 | Start Trial |
| Vilaprisan | Canada | 2768407 | 2029-07-20 | Start Trial |
| Vilaprisan | Chile | 2012000166 | 2029-07-20 | Start Trial |
| Vilaprisan | China | 102482317 | 2029-07-20 | Start Trial |
| Vilaprisan | Colombia | 6491067 | 2029-07-20 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
